Sudden cardiac death and arrhythmia-related events in patients with non-ischaemic dilated
cardiomyopathy (NICM) have been significantly reduced over the last couple of decades as …

The foundation of the treatment of heart failure with reduced ejection fraction is a number of
pharmacotherapies shown to reduce morbidity and mortality in large randomised …

Data is lacking on the contemporary risk of death and readmission following implantable
cardioverter-defibrillator (ICD) implantation in patients with non-ischemic cardiomyopathies …

Background Primary prophylactic implantable cardioverter-defibrillators (ICDs) in patients
with non-ischaemic cardiomyopathy (NICMP) remains controversial. This study sought to …

Introduction and objectives This article presents data on implantable cardioverter-
defibrillator implants in Spain in 2022. Methods The data were collected from implantation …

Background Cardiac resynchronization therapy (CRT) is a major device therapy used to
treat patients suffering from heart failure (HF) and electrical asynchrony. It can improve HF …

Sudden cardiac death (SCD) represents a major challenge in modern medicine. The
prevention of SCD orbits on two levels, the general population level and individual level …

Background Evidence regarding the mortality benefit of implantable cardioverter defibrillator
(ICD) non-ischemic dilated cardiomyopathy (NIDCM) is inconsistent. The most recent …

Aims To assess the barriers to guideline-directed medical therapy (GDMT) use in heart
failure (HF), diagnostic workup and general knowledge about HF among physicians in …

Background The wearable cardioverter defibrillator (WCD),(LifeVest, ZOLL, Pittsburgh, PA,
USA) is a medical device designed for the temporary detection and treatment of malignant …